|
|
|
|
|
| Prospectus synopsis |
| |
|
|
Phone:+91 70965 58558 Fax:
|
| initial public issue of 21,50,000 equity shares of face value of Rs. 10/- each of Curis Lifesciences Limited ("Curis" or the "company" or the "Issuer") for cash at a price of Rs. 128/- per equity share including a share premium of Rs. 118/- per equity share (the "Issue Price") aggregating to Rs. 27.52 crores ("the Issue"), of which 1,08,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 128/- per equity share including a share premium of Rs. 118/- per equity share aggregating to Rs. 1.38 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 20,42,000 equity shares of face value of
Rs. 10/- each at a price of Rs. 128/- per equity share including a share premium of Rs.118/- per equity share aggregating to Rs. 26.14 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.59% and 25.26%, respectively, of the post issue paid up equity share capital of the company.
|
| 07-Nov-25 |
11-Nov-25 |
Rs
128.00-0.00
|
Rs
0.00-0.00
|
| Minimum Application for shares in Nos :
2000
Further Multiples of :
1000
|
| Project Cost |
0.00 |
| Finaax Capital Advisors Private Limited |
|
| Project Financed through Current Offer |
27.52 |
|
| Post Issue Equity Share Capital |
8.08 |
|
| Issue Price |
Rs.128.00
|
|
|
|
|
| |
|
| No Data Found. |
|
|
|
|
|
|
|
|
|
|
|
|
|